 Alia Al-Tayyib
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 11 | 2026 | 127 | 2.730 |
Why?
| | Amphetamine-Related Disorders | 5 | 2026 | 52 | 1.880 |
Why?
| | Opioid-Related Disorders | 8 | 2025 | 600 | 1.820 |
Why?
| | Methamphetamine | 6 | 2026 | 74 | 1.780 |
Why?
| | Homosexuality, Male | 8 | 2022 | 231 | 1.440 |
Why?
| | Hepatitis C | 8 | 2026 | 256 | 1.180 |
Why?
| | Methadone | 2 | 2025 | 122 | 1.090 |
Why?
| | Patient Navigation | 2 | 2026 | 126 | 1.030 |
Why?
| | Opiate Substitution Treatment | 3 | 2025 | 186 | 1.010 |
Why?
| | Analgesics, Opioid | 6 | 2025 | 1145 | 0.970 |
Why?
| | HIV Infections | 21 | 2026 | 3186 | 0.930 |
Why?
| | Prescription Drug Misuse | 2 | 2017 | 52 | 0.890 |
Why?
| | Gonorrhea | 4 | 2012 | 63 | 0.860 |
Why?
| | Sexual Behavior | 10 | 2022 | 494 | 0.850 |
Why?
| | Heroin Dependence | 2 | 2017 | 33 | 0.820 |
Why?
| | Drug Overdose | 6 | 2026 | 374 | 0.800 |
Why?
| | Chlamydia Infections | 5 | 2012 | 79 | 0.730 |
Why?
| | Emergency Service, Hospital | 13 | 2025 | 2377 | 0.720 |
Why?
| | Colorado | 15 | 2026 | 4538 | 0.670 |
Why?
| | Unsafe Sex | 4 | 2017 | 61 | 0.630 |
Why?
| | Needle-Exchange Programs | 3 | 2026 | 15 | 0.630 |
Why?
| | Sexual Partners | 6 | 2018 | 193 | 0.620 |
Why?
| | Mass Screening | 11 | 2025 | 1354 | 0.590 |
Why?
| | Internet | 2 | 2017 | 689 | 0.550 |
Why?
| | Substance-Related Disorders | 6 | 2025 | 1093 | 0.540 |
Why?
| | Buprenorphine | 1 | 2021 | 190 | 0.540 |
Why?
| | Hepacivirus | 5 | 2025 | 242 | 0.490 |
Why?
| | Adult | 40 | 2026 | 40665 | 0.480 |
Why?
| | Prescription Drugs | 1 | 2016 | 110 | 0.430 |
Why?
| | Male | 46 | 2026 | 72664 | 0.410 |
Why?
| | Mobile Applications | 1 | 2017 | 199 | 0.410 |
Why?
| | Homeless Youth | 1 | 2013 | 23 | 0.390 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 279 | 0.380 |
Why?
| | Middle Aged | 25 | 2026 | 36126 | 0.370 |
Why?
| | Primary Prevention | 1 | 2014 | 218 | 0.360 |
Why?
| | Risk-Taking | 8 | 2020 | 323 | 0.350 |
Why?
| | Public Health | 1 | 2016 | 571 | 0.340 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2020 | 1415 | 0.330 |
Why?
| | Humans | 54 | 2026 | 145140 | 0.330 |
Why?
| | Female | 38 | 2026 | 78636 | 0.320 |
Why?
| | Social Stigma | 2 | 2022 | 172 | 0.300 |
Why?
| | Comorbidity | 3 | 2021 | 1657 | 0.300 |
Why?
| | Attitude | 1 | 2011 | 258 | 0.290 |
Why?
| | Heterosexuality | 3 | 2018 | 46 | 0.290 |
Why?
| | Young Adult | 16 | 2024 | 14176 | 0.280 |
Why?
| | Telephone | 2 | 2009 | 177 | 0.280 |
Why?
| | Safety-net Providers | 2 | 2020 | 129 | 0.280 |
Why?
| | Heroin | 2 | 2020 | 29 | 0.280 |
Why?
| | Prevalence | 6 | 2019 | 2855 | 0.270 |
Why?
| | Health Services Accessibility | 4 | 2025 | 1099 | 0.270 |
Why?
| | Adolescent | 20 | 2021 | 22479 | 0.270 |
Why?
| | Surveys and Questionnaires | 4 | 2017 | 6055 | 0.260 |
Why?
| | Self Disclosure | 2 | 2009 | 61 | 0.240 |
Why?
| | United States | 19 | 2026 | 16065 | 0.240 |
Why?
| | Financing, Government | 1 | 2026 | 53 | 0.230 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 640 | 0.230 |
Why?
| | Cities | 4 | 2020 | 138 | 0.230 |
Why?
| | Models, Economic | 1 | 2025 | 61 | 0.220 |
Why?
| | Interviews as Topic | 4 | 2024 | 907 | 0.210 |
Why?
| | Housing | 1 | 2025 | 142 | 0.210 |
Why?
| | Psychoses, Substance-Induced | 1 | 2024 | 16 | 0.210 |
Why?
| | Chlamydia trachomatis | 3 | 2008 | 49 | 0.200 |
Why?
| | Behavioral Risk Factor Surveillance System | 4 | 2017 | 57 | 0.190 |
Why?
| | Prospective Studies | 7 | 2026 | 8035 | 0.190 |
Why?
| | Socioeconomic Factors | 6 | 2020 | 1321 | 0.190 |
Why?
| | Baltimore | 3 | 2008 | 72 | 0.180 |
Why?
| | Health Care Costs | 1 | 2026 | 425 | 0.180 |
Why?
| | Health Surveys | 2 | 2009 | 517 | 0.170 |
Why?
| | Family Planning Services | 1 | 2022 | 93 | 0.170 |
Why?
| | Insurance, Health | 2 | 2015 | 310 | 0.170 |
Why?
| | Needle Sharing | 1 | 2020 | 10 | 0.160 |
Why?
| | Sexual and Gender Minorities | 2 | 2022 | 259 | 0.160 |
Why?
| | Educational Status | 1 | 2002 | 465 | 0.160 |
Why?
| | Patient-Centered Care | 1 | 2025 | 547 | 0.160 |
Why?
| | Risk | 2 | 2016 | 916 | 0.160 |
Why?
| | Drug Users | 1 | 2020 | 43 | 0.150 |
Why?
| | Allied Health Personnel | 1 | 2020 | 53 | 0.150 |
Why?
| | Washington | 2 | 2020 | 149 | 0.140 |
Why?
| | Neisseria gonorrhoeae | 2 | 2008 | 29 | 0.140 |
Why?
| | HIV | 3 | 2019 | 251 | 0.130 |
Why?
| | Cohort Studies | 3 | 2025 | 5988 | 0.130 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2020 | 268 | 0.120 |
Why?
| | Qualitative Research | 1 | 2024 | 1671 | 0.120 |
Why?
| | Condoms | 2 | 2014 | 102 | 0.120 |
Why?
| | Patient Participation | 1 | 2019 | 437 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 881 | 0.110 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 103 | 0.110 |
Why?
| | Interpersonal Relations | 1 | 2018 | 397 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2020 | 494 | 0.110 |
Why?
| | Public Health Surveillance | 1 | 2015 | 83 | 0.110 |
Why?
| | Reproductive Health | 1 | 2015 | 91 | 0.110 |
Why?
| | Health Care Reform | 1 | 2015 | 109 | 0.110 |
Why?
| | Emergency Medical Services | 2 | 2020 | 684 | 0.110 |
Why?
| | Insurance Coverage | 2 | 2015 | 244 | 0.100 |
Why?
| | Machine Learning | 1 | 2020 | 586 | 0.100 |
Why?
| | Sexually Transmitted Diseases | 1 | 2015 | 168 | 0.100 |
Why?
| | Contact Tracing | 1 | 2012 | 26 | 0.090 |
Why?
| | Equivalence Trials as Topic | 2 | 2023 | 35 | 0.090 |
Why?
| | AIDS Serodiagnosis | 1 | 2012 | 23 | 0.090 |
Why?
| | Hepatitis C Antibodies | 1 | 2011 | 11 | 0.090 |
Why?
| | Sex Factors | 1 | 2017 | 2099 | 0.090 |
Why?
| | Risk Assessment | 2 | 2025 | 3740 | 0.080 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 96 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1546 | 0.080 |
Why?
| | Health Promotion | 1 | 2017 | 774 | 0.080 |
Why?
| | Cross-Sectional Studies | 3 | 2011 | 5886 | 0.070 |
Why?
| | Urban Population | 2 | 2012 | 492 | 0.070 |
Why?
| | ROC Curve | 1 | 2011 | 617 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2013 | 472 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2023 | 11741 | 0.060 |
Why?
| | Tape Recording | 1 | 2005 | 10 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2023 | 1742 | 0.060 |
Why?
| | Harm Reduction | 1 | 2026 | 49 | 0.060 |
Why?
| | Monte Carlo Method | 1 | 2026 | 147 | 0.060 |
Why?
| | Life Expectancy | 1 | 2025 | 73 | 0.050 |
Why?
| | Bias | 1 | 2005 | 197 | 0.050 |
Why?
| | Alcoholism | 2 | 2020 | 819 | 0.050 |
Why?
| | Age Factors | 2 | 2009 | 3338 | 0.050 |
Why?
| | Risk Factors | 3 | 2019 | 10857 | 0.050 |
Why?
| | Hospitalization | 2 | 2026 | 2458 | 0.050 |
Why?
| | Data Collection | 1 | 2005 | 639 | 0.050 |
Why?
| | Logistic Models | 1 | 2008 | 2133 | 0.050 |
Why?
| | Central Nervous System Stimulants | 1 | 2024 | 185 | 0.050 |
Why?
| | Sex Education | 1 | 2022 | 34 | 0.050 |
Why?
| | Pregnancy, Unplanned | 1 | 2022 | 48 | 0.040 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2022 | 132 | 0.040 |
Why?
| | RNA, Viral | 1 | 2025 | 690 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 79 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2008 | 3616 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 410 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1844 | 0.040 |
Why?
| | Oregon | 1 | 2020 | 76 | 0.040 |
Why?
| | Contraception | 1 | 2022 | 170 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1845 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 221 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 1082 | 0.030 |
Why?
| | Aged | 2 | 2016 | 26096 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2020 | 287 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2024 | 862 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 552 | 0.030 |
Why?
| | Gender Identity | 1 | 2018 | 128 | 0.030 |
Why?
| | Family | 1 | 2022 | 682 | 0.030 |
Why?
| | Self Efficacy | 1 | 2020 | 410 | 0.030 |
Why?
| | Medicaid | 1 | 2020 | 466 | 0.030 |
Why?
| | Minority Groups | 1 | 2018 | 284 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 946 | 0.030 |
Why?
| | Censuses | 1 | 2015 | 33 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 832 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1188 | 0.030 |
Why?
| | Cognition | 1 | 2002 | 1262 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 767 | 0.020 |
Why?
| | Phylogeny | 1 | 2017 | 917 | 0.020 |
Why?
| | Research Design | 1 | 2019 | 1132 | 0.020 |
Why?
| | Medical Assistance | 1 | 2012 | 13 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2012 | 142 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2012 | 266 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2008 | 17247 | 0.020 |
Why?
| | Comprehension | 1 | 2012 | 184 | 0.020 |
Why?
| | Saliva | 1 | 2011 | 245 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2011 | 153 | 0.020 |
Why?
| | Child | 2 | 2020 | 22670 | 0.020 |
Why?
| | Triage | 1 | 2012 | 250 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7182 | 0.020 |
Why?
| | Computers | 1 | 2009 | 66 | 0.020 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2009 | 75 | 0.020 |
Why?
| | Contraception Behavior | 1 | 2009 | 108 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2009 | 165 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 484 | 0.020 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2007 | 39 | 0.020 |
Why?
| | Urban Health | 1 | 2007 | 96 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 1058 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1995 | 0.020 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2005 | 92 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3410 | 0.010 |
Why?
|
|
Al-Tayyib's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|